Daegu, South Korea

Jong Oh Kim

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Industry-University Cooperation Foundation Hanyang University. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jong Oh Kim. Retrieved from https://idiyas.com/inventor/jong-oh-kim-i0ihlr9b

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Jong Oh Kim

Introduction

Jong Oh Kim is a notable inventor based in Daegu, South Korea. He has made significant strides in the field of medical formulations, particularly with his innovative work on drug delivery systems. His contributions are particularly relevant in the context of cancer treatment.

Latest Patents

One of Jong Oh Kim's most recent patents is the "Irinotecan-loaded dual-reverse thermosensitive hydrogel composition." This formulation includes nanoparticles containing irinotecan and lipids, a hydrogel, and a stabilizer. This innovative approach aims to enhance the efficacy of irinotecan, a chemotherapy drug, by improving its delivery and stability.

Career Highlights

Jong Oh Kim is affiliated with the Industry-University Cooperation Foundation at Hanyang University. His work there focuses on bridging the gap between academic research and practical applications in the industry. His dedication to advancing medical technology is evident in his research and patent contributions.

Collaborations

Throughout his career, Jong Oh Kim has collaborated with esteemed colleagues, including Han-Gon Choi and Fakhar Ud Din. These partnerships have fostered a collaborative environment that encourages innovation and the development of new technologies.

Conclusion

Jong Oh Kim's contributions to the field of medical formulations, particularly through his patented innovations, highlight his role as a key figure in advancing cancer treatment technologies. His work exemplifies the importance of collaboration and innovation in the medical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…